TruBridge ROA 2012-2025 | TBRG
Current and historical return on assets (ROA) values for TruBridge (TBRG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| TruBridge ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.00B | $0.40B | 0.76% |
| 2025-06-30 | $-0.01B | $0.39B | -2.79% |
| 2025-03-31 | $-0.02B | $0.39B | -4.51% |
| 2024-12-31 | $-0.02B | $0.39B | -4.93% |
| 2024-09-30 | $-0.06B | $0.40B | -14.20% |
| 2024-06-30 | $-0.05B | $0.41B | -12.54% |
| 2024-03-31 | $-0.05B | $0.42B | -12.14% |
| 2023-12-31 | $-0.05B | $0.43B | -10.84% |
| 2023-09-30 | $0.00B | $0.43B | -0.23% |
| 2023-06-30 | $0.00B | $0.44B | 0.92% |
| 2023-03-31 | $0.01B | $0.44B | 2.28% |
| 2022-12-31 | $0.02B | $0.43B | 3.42% |
| 2022-09-30 | $0.02B | $0.44B | 4.22% |
| 2022-06-30 | $0.02B | $0.45B | 4.59% |
| 2022-03-31 | $0.02B | $0.44B | 5.49% |
| 2021-12-31 | $0.02B | $0.38B | 4.82% |
| 2021-09-30 | $0.02B | $0.39B | 4.45% |
| 2021-06-30 | $0.02B | $0.39B | 5.21% |
| 2021-03-31 | $0.01B | $0.33B | 4.21% |
| 2020-12-31 | $0.01B | $0.33B | 4.20% |
| 2020-09-30 | $0.02B | $0.33B | 6.53% |
| 2020-06-30 | $0.02B | $0.34B | 6.19% |
| 2020-03-31 | $0.02B | $0.34B | 6.17% |
| 2019-12-31 | $0.02B | $0.34B | 5.90% |
| 2019-09-30 | $0.02B | $0.34B | 4.76% |
| 2019-06-30 | $0.02B | $0.35B | 5.41% |
| 2019-03-31 | $0.02B | $0.33B | 4.89% |
| 2018-12-31 | $0.02B | $0.33B | 5.22% |
| 2018-09-30 | $-0.01B | $0.33B | -3.40% |
| 2018-06-30 | $-0.02B | $0.32B | -4.59% |
| 2018-03-31 | $-0.01B | $0.33B | -3.93% |
| 2017-12-31 | $-0.02B | $0.32B | -5.09% |
| 2017-09-30 | $0.01B | $0.34B | 1.77% |
| 2017-06-30 | $0.01B | $0.34B | 1.77% |
| 2017-03-31 | $0.01B | $0.34B | 1.76% |
| 2016-12-31 | $0.00B | $0.34B | 1.15% |
| 2016-09-30 | $0.01B | $0.34B | 1.75% |
| 2016-06-30 | $0.01B | $0.35B | 2.67% |
| 2016-03-31 | $0.01B | $0.36B | 6.16% |
| 2015-12-31 | $0.02B | $0.09B | 17.44% |
| 2015-09-30 | $0.02B | $0.10B | 21.21% |
| 2015-06-30 | $0.03B | $0.10B | 27.07% |
| 2015-03-31 | $0.03B | $0.10B | 30.15% |
| 2014-12-31 | $0.03B | $0.10B | 33.08% |
| 2014-09-30 | $0.04B | $0.10B | 36.64% |
| 2014-06-30 | $0.03B | $0.10B | 35.70% |
| 2014-03-31 | $0.03B | $0.10B | 35.68% |
| 2013-12-31 | $0.03B | $0.09B | 36.47% |
| 2013-09-30 | $0.03B | $0.09B | 37.01% |
| 2013-06-30 | $0.03B | $0.09B | 37.46% |
| 2013-03-31 | $0.03B | $0.08B | 38.04% |
| 2012-12-31 | $0.03B | $0.08B | 37.15% |
| 2012-09-30 | $0.03B | $0.09B | 34.78% |
| 2012-06-30 | $0.03B | $0.08B | 34.95% |
| 2012-03-31 | $0.03B | $0.08B | 36.00% |
| 2011-12-31 | $0.03B | $0.08B | 35.86% |
| 2011-09-30 | $0.03B | $0.07B | 37.55% |
| 2011-06-30 | $0.03B | $0.07B | 37.74% |
| 2011-03-31 | $0.02B | $0.07B | 33.60% |
| 2010-12-31 | $0.02B | $0.06B | 32.34% |
| 2010-09-30 | $0.02B | $0.06B | 28.32% |
| 2010-06-30 | $0.02B | $0.06B | 27.40% |
| 2010-03-31 | $0.02B | $0.06B | 27.78% |
| 2009-12-31 | $0.02B | $0.05B | 29.77% |
| 2009-09-30 | $0.02B | $0.05B | 31.78% |
| 2009-06-30 | $0.02B | $0.05B | 31.92% |
| 2009-03-31 | $0.02B | $0.05B | 30.77% |
| 2008-12-31 | $0.02B | $0.05B | 31.37% |
| 2008-09-30 | $0.02B | $0.05B | 29.85% |
| 2008-06-30 | $0.01B | $0.05B | 28.28% |
| 2008-03-31 | $0.01B | $0.05B | 28.28% |
| 2007-12-31 | $0.01B | $0.05B | 26.80% |
| 2007-09-30 | $0.01B | $0.05B | 27.08% |
| 2007-06-30 | $0.01B | $0.05B | 27.37% |
| 2007-03-31 | $0.01B | $0.05B | 29.79% |
| 2006-12-31 | $0.02B | $0.05B | 31.75% |
| 2006-09-30 | $0.02B | $0.05B | 31.91% |
| 2006-06-30 | $0.02B | $0.05B | 34.59% |
| 2006-03-31 | $0.02B | $0.05B | 33.33% |
| 2005-12-31 | $0.01B | $0.05B | 32.37% |
| 2005-09-30 | $0.01B | $0.04B | 32.10% |
| 2005-06-30 | $0.01B | $0.04B | 28.95% |
| 2005-03-31 | $0.01B | $0.04B | 25.53% |
| 2004-12-31 | $0.01B | $0.04B | 21.21% |
| 2004-09-30 | $0.01B | $0.03B | 18.90% |
| 2004-06-30 | $0.01B | $0.03B | 16.13% |
| 2004-03-31 | $0.01B | $0.03B | 19.67% |
| 2003-12-31 | $0.01B | $0.03B | 23.33% |
| 2003-09-30 | $0.01B | $0.03B | 23.73% |
| 2003-06-30 | $0.01B | $0.03B | 27.83% |
| 2003-03-31 | $0.01B | $0.03B | 32.43% |
| 2002-12-31 | $0.01B | $0.03B | 48.78% |
| 2002-09-30 | $0.01B | $0.03B | 75.47% |
| 2002-06-30 | $0.01B | $0.03B | 160.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.293B | $0.339B |
| TruBridge Inc. is a healthcare solutions company. TruBridge Inc. is based in MOBILE, Ala. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |